Meeting
2018 ASCO Annual Meeting
Management and outcome of patients with neo-adjuvant chemotherapy (CT) in locally advanced soft-tissue sarcoma (LASTS): The Gustave Roussy experience.
Authors
Sarah Naomie Dumont
Gustave Roussy Cancer Campus, Villejuif, France
Sarah Naomie Dumont , Elena Cojocaru , Matthieu Faron , Leila Haddag , Jean Francois Honart , Nicolas Kiavue , Françoise Rimareix , Antonin Levy , Cecile Le Pechoux , Angela Botticella , Philippe Terrier , Julien Adam , Olivier Mir , Andrea Cavalcanti , Charles Honoré , Axel Le Cesne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 36, 2018 (suppl; abstr 11580)
DOI
10.1200/JCO.2018.36.15_suppl.11580
Abstract #
11580
Poster Bd #
325
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
The impact of multimodality therapies in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program (TSP) experience.
First Author: Olga Vornicova
Poster
2016 ASCO Annual Meeting
The impact of multimodality therapy in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program Experience.
First Author: Samer Salah
Poster
2013 ASCO Annual Meeting
Nuclear SMAD4 as a predictor of survival in patientes with extremity soft tissue sarcomas submitted to neoadjuvant chemotherapy.
First Author: Isabela Werneck Cunha
Poster
2021 ASCO Annual Meeting
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts).
First Author: Carlo Resteghini